We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$830B
AUM Growth
-$35.6B
Cap. Flow
+$7.17B
Cap. Flow %
0.86%
Top 10 Hldgs %
17.54%
Holding
7,378
New
607
Increased
2,657
Reduced
2,665
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Healthcare 10.88%
3 Financials 10.81%
4 Consumer Discretionary 8.58%
5 Industrials 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BODI icon
6251
The Beachbody Company
BODI
$47.6M
$1K ﹤0.01%
12
-2
-14% -$204
RNTX
6252
Rein Therapeutics
RNTX
$67.4M
$1K ﹤0.01%
+55
New +$498
GATE
6253
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1K ﹤0.01%
100
TBNK
6254
DELISTED
Territorial Bancorp Inc.
TBNK
$1K ﹤0.01%
25
NVACR
6255
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$1K ﹤0.01%
+8,755
New +$1.47K
CNTG
6256
DELISTED
Centogene N.V. Common Shares
CNTG
$1K ﹤0.01%
245
-7,044
-97% -$29.6K
BTCY
6257
DELISTED
Biotricity, Inc. Common Stock
BTCY
$1K ﹤0.01%
+84
New +$1.46K
FRLN
6258
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$1K ﹤0.01%
+44
New +$816
IBDO
6259
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$1K ﹤0.01%
35
-360
-91% -$9.16K
AXLA
6260
DELISTED
Axcella Health Inc. Common Stock
AXLA
$1K ﹤0.01%
8
SAL
6261
DELISTED
Salisbury Bancorp, Inc.
SAL
$1K ﹤0.01%
26
ARVL
6262
DELISTED
Arrival Ordinary Shares
ARVL
$1K ﹤0.01%
4
QTT
6263
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$1K ﹤0.01%
447
-1,097
-71% -$2.22K
PDOT.WS
6264
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
0
FPAC
6265
DELISTED
Far Peak Acquisition Corporation
FPAC
$1K ﹤0.01%
114
+90
+375% +$894
MSAC
6266
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$1K ﹤0.01%
100
MTCR
6267
DELISTED
Metacrine, Inc. Common Stock
MTCR
$1K ﹤0.01%
+1,038
New +$544
ZNH
6268
DELISTED
China Southern Airlines Company Limited
ZNH
$1K ﹤0.01%
50
VGFC
6269
DELISTED
The Very Good Food Company
VGFC
$1K ﹤0.01%
+492
New +$284
KAHC.WS
6270
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
0
CHAA.WS
6271
DELISTED
Catcha Investment Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHAA.WS
0
HSTO
6272
DELISTED
Histogen Inc. Common Stock
HSTO
$1K ﹤0.01%
+172
New +$871
ZNTE
6273
DELISTED
Zanite Acquisition Corp. Class A Common Stock
ZNTE
$1K ﹤0.01%
87
NBRV
6274
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1K ﹤0.01%
+129
New +$1.57K
ZOM
6275
DELISTED
Zomedica Corp.
ZOM
$1K ﹤0.01%
5,029

Similar funds

JP Morgan Chase's Q1 2022 Portfolio in Review

As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
  • JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
  • JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
  • JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
  • JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
  • JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.

Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.